| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | CERNER CORP | 86,000 | 4,555,000 | 0.90% | ||
| 52 | EDWARDS LIFESCIENCES CORP | 55,000 | 4,852,000 | 0.96% | ||
| 53 | HUMANA INC | 27,000 | 4,940,000 | 0.98% | ||
| 54 | DEPHEID | 150,000 | 5,004,000 | 0.99% | ||
| 55 | DEXCOM INC | 75,000 | 5,093,000 | 1.01% | ||
| 56 | AMERISOURCEBERGEN CORP | 63,000 | 5,453,000 | 1.08% | ||
| 57 | COOPER COS INC | 40,000 | 6,159,000 | 1.22% | ||
| 58 | VERTEX PHARMACEUTICALS INC | 78,000 | 6,200,000 | 1.23% | ||
| 59 | MCKESSON CORP | 40,000 | 6,290,000 | 1.25% | ||
| 60 | ANTHEM INC | 47,000 | 6,533,000 | 1.30% | ||
| 61 | AMGEN INC | 45,000 | 6,747,000 | 1.34% | ||
| 62 | NEKTAR THERAPEUTICS COM | 525,000 | 7,219,000 | 1.43% | ||
| 63 | EXPRESS SCRIPTS HLDG CO | 106,000 | 7,281,000 | 1.45% | ||
| 64 | ENDO INTL PLC | 260,000 | 7,319,000 | 1.45% | ||
| 65 | ABBVIE INC | 130,000 | 7,426,000 | 1.47% | ||
| 66 | AETNA INC NEW | 67,000 | 7,527,000 | 1.49% | ||
| 67 | CARDINAL HEALTH INC | 92,000 | 7,539,000 | 1.50% | ||
| 68 | UNITEDHEALTH GROUP INC | 60,000 | 7,734,000 | 1.54% | ||
| 69 | PERRIGO CO PLC | 61,000 | 7,804,000 | 1.55% | ||
| 70 | ALNYLAM PHARMACEUTICALS INC | 125,000 | 7,846,000 | 1.56% | ||
| 71 | HCA HOLDINGS INC | 104,000 | 8,117,000 | 1.61% | ||
| 72 | WALGREENS BOOTS ALLIANCE INC | 100,000 | 8,424,000 | 1.67% | ||
| 73 | MEDIVATION INC | 187,000 | 8,598,000 | 1.71% | ||
| 74 | CENTENE CORP DEL | 141,712 | 8,725,000 | 1.73% | ||
| 75 | LABORATORY CORP AMER HLDGS | 75,000 | 8,785,000 | 1.74% | ||
| 76 | BRISTOL MYERS SQUIBB CO | 142,000 | 9,071,000 | 1.80% | ||
| 77 | CIGNA CORPORATION | 69,000 | 9,470,000 | 1.88% | ||
| 78 | ZIMMER BIOMET HLDGS INC | 91,000 | 9,703,000 | 1.93% | ||
| 79 | BIOGEN INC | 38,000 | 9,892,000 | 1.96% | ||
| 80 | ST JUDE MED INC | 180,000 | 9,900,000 | 1.97% | ||
| 81 | MEDTRONIC PLC | 137,000 | 10,275,000 | 2.04% | ||
| 82 | CVS HEALTH CORP | 105,000 | 10,892,000 | 2.16% | ||
| 83 | ALLERGAN PLC | 42,000 | 11,257,000 | 2.23% | ||
| 84 | ABIOMED INC | 125,000 | 11,851,000 | 2.35% | ||
| 85 | CELGENE CORP | 120,000 | 12,011,000 | 2.38% | ||
| 86 | INCYTE CORP | 170,000 | 12,320,000 | 2.45% | ||
| 87 | ALKERMES PLC | 405,000 | 13,847,000 | 2.75% | ||
| 88 | LILLY ELI & CO | 195,000 | 14,042,000 | 2.79% | ||
| 89 | PFIZER INC | 475,000 | 14,079,000 | 2.79% | ||
| 90 | BIOMARIN PHARMACEUTICAL INC | 190,000 | 15,671,000 | 3.11% | ||
| 91 | GILEAD SCIENCES INC | 180,000 | 16,535,000 | 3.28% | ||
| 92 | ALEXION PHARMACEUTIC | 121,000 | 16,846,000 | 3.34% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-005562, filed 2016.04.19).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
